Jeff Castelli

Jeff Castelli is a declared insider of Amicus Therapeutics, Inc., with filings sourced from SEC (Form 4). We count 48 filings; the first trade dates from 10 April 2014 and the latest from 27 April 2026.

The open-market side counts 3 purchases for €148k alongside 13 sales for €2.0M. Sales outweigh purchases by €1.9M. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 25 share grants and 6 option exercises.

A typical purchase (the median) is worth €48k.

The record was last updated on 27 April 2026 with a transaction (€5.3M) in Amicus Therapeutics, Inc. The latest purchase dates back some time: it was published 4,351 days ago, on 25 November 2014. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.